Podcast•Dec 10, 2025•37 min
Determining the Cause and Severity of Sepsis with a Point-of-Care Test
In this episode of The Bio Report, host Daniel Levine interviews Tim Sweeney, CEO of Inflammatix, about the company's TriVerity point‑of‑care test that rapidly distinguishes bacterial from viral infections and gauges immune response severity in sepsis patients. Sweeney explains how the test works, its integration into emergency‑room workflows, and its potential to guide antibiotic use, ICU admission decisions, and broader diagnostics, addressing the costly and treatment‑resistant nature of sepsis. The discussion highlights the broader challenge of sepsis drug development and positions TriVerity as a pragmatic tool to improve patient outcomes and reduce healthcare spending.
